Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin. World J Gastroenterol 2009; 15(21): 2628-2631 [PMID: 19496193 DOI: 10.3748/wjg.15.2628]
Corresponding Author of This Article
Dr. Sergio Peralta, Chair of Gastroenterology, Operative Unit of Gastroenterology and Hepatology, Di.Bi.M.I.S, Piazza delle Cliniche 2, Palermo 90127, Italy. peralta.sergio@yahoo.it
Article-Type of This Article
Brief Articles
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/